Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia
Authors
Keywords
Telangiectasia, Hereditary, Epistaxis, Anemia, Tyrosine kinase inhibitor
Journal
ANGIOGENESIS
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-06
DOI
10.1007/s10456-018-9646-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia–Related Epistaxis and Gastrointestinal Bleeding
- (2018) Vivek N. Iyer et al. MAYO CLINIC PROCEEDINGS
- Selective effects of oral antiangiogenic tyrosine kinase inhibitors on an animal model of hereditary hemorrhagic telangiectasia
- (2017) Y. H. Kim et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia
- (2016) Kevin J. Whitehead et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia
- (2016) Sophie Dupuis-Girod et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dose – response relationship of bevacizumab in hereditary hemorrhagic telangiectasia
- (2015) Nicolas Azzopardi et al. mAbs
- VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2
- (2014) Chul Han et al. ANGIOGENESIS
- Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double-blind, randomized, placebo-controlled trial
- (2014) Dominik Riss et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease
- (2014) S. Gaillard et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid - a double-blind placebo-controlled cross-over phase IIIB study
- (2014) Urban W. Geisthoff et al. THROMBOSIS RESEARCH
- Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Weber-Rendu)
- (2014) John E. Hanks et al. International Forum of Allergy & Rhinology
- The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia
- (2014) Christian A. Merlo et al. International Forum of Allergy & Rhinology
- The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study
- (2013) J W Donaldson et al. THORAX
- Management of Antiangiogenic Therapy-Induced Hypertension
- (2012) Nilka de Jesus-Gonzalez et al. HYPERTENSION
- Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output
- (2012) Sophie Dupuis-Girod et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Bevacizumab Attenuates VEGF-Induced Angiogenesis and Vascular Malformations in the Adult Mouse Brain
- (2012) Espen J. Walker et al. STROKE
- Arteriovenous malformation in the adult mouse brain resembling the human disease
- (2010) Espen J. Walker et al. ANNALS OF NEUROLOGY
- An epistaxis severity score for hereditary hemorrhagic telangiectasia
- (2010) Jeffrey B. Hoag et al. LARYNGOSCOPE
- Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib
- (2009) Kyoichi Takahashi ARCHIVES OF OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started